Table 3.
Treatments received stratified by comorbidity (patients with asymptomatic or incidental SARS-CoV-2 infections excluded).
| Total N | No/Unknown comorbidity | Comorbidity present | p | ||
|---|---|---|---|---|---|
| Total N (%) | 938 (58.0) | 679 (42.0) | |||
| Antibiotic medication | 1477 (91.3) | No | 301 (32.1) | 216 (31.8) | 0.273 |
| Yes | 529 (56.4) | 431 (63.5) | |||
| (Missing) | 108 (11.5) | 32 (4.7) | |||
| Antiviral | 1476 (91.3) | No | 787 (83.9) | 595 (87.6) | 0.027 |
| Yes | 42 (4.5) | 52 (7.7) | |||
| (Missing) | 109 (11.6) | 32 (4.7) | |||
| Maximal steroid therapy | 1422 (87.9) | None | 713 (76.0) | 475 (70.0) | <0.001 |
| Oral | 53 (5.7) | 103 (15.2) | |||
| IV | 42 (4.5) | 36 (5.3) | |||
| (Missing) | 130 (13.9) | 65 (9.6) | |||
| Maximum respiratory support | 1550 (95.9) | No respiratory support | 738 (78.7) | 427 (62.9) | <0.001 |
| Supplemental oxygen | 59 (6.3) | 108 (15.9) | |||
| High flow support | 21 (2.2) | 47 (6.9) | |||
| Non-invasive | 25 (2.7) | 35 (5.2) | |||
| Invasive | 33 (3.5) | 57 (8.4) | |||
| (Missing) | 62 (6.6) | 5 (0.7) | |||
| ICU/HDU admission | 1548 (95.7) | No | 764 (81.4) | 536 (78.9) | <0.001 |
| Yes | 112 (11.9) | 136 (20.0) | |||
| (Missing) | 62 (6.6) | 7 (1.0) | |||
| Inotrope | 1451 (89.7) | No | 764 (81.4) | 612 (90.1) | 0.274 |
| Yes | 47 (5.0) | 28 (4.1) | |||
| (Missing) | 127 (13.5) | 39 (5.7) | |||
| Total PEWS | 1518 (93.9) | Median (IQR) | 2.0 (1.0–4.0) | 2.0 (1.0–5.0) | 0.014 |
| PEWS over 2 | 1518 (93.9) | No | 471 (50.2) | 351 (51.7) | 0.315 |
| Yes | 380 (40.5) | 316 (46.5) | |||
| (Missing) | 87 (9.3) | 12 (1.8) | |||
| Length of stay | 1368 (84.6) | Median (IQR) | 2.0 (1.0–3.0) | 3.0 (1.0–7.0) | <0.001 |
ICU intensive care unit, HDU high dependency unit, PEWS Paediatric Early Warning Score at presentation.